Eligibility is determined by a licensed provider based on your medical history, BMI, and overall health
adults found that nearly two thirds of non-diabetic patients (64.8%) discontinued their GLP-1 therapy within one year
We offer access to novel trials and therapies, some of which are only available here at Childrens National
-Glutamyl-L-cysteine peptides include an array of water-soluble dipeptides, including -glutamyl-S-allyl-L-cysteine, -glutamylmethylcysteine, and -glutamylpropylcysteine (see Figure 1 )
Frequently Asked Questions Youll meet with a licensed medical professional who reviews your health goals and recommends the best IV therapy for your needs
Researchers found in a mouse model that sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and inflammation